Peter Oladimeji

650 total citations
17 papers, 519 citations indexed

About

Peter Oladimeji is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Peter Oladimeji has authored 17 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Cell Biology. Recurrent topics in Peter Oladimeji's work include Drug Transport and Resistance Mechanisms (3 papers), Microtubule and mitosis dynamics (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Peter Oladimeji is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Microtubule and mitosis dynamics (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Peter Oladimeji collaborates with scholars based in United States, United Kingdom and China. Peter Oladimeji's co-authors include Taosheng Chen, Maria Diakonova, Leah Rider, Chen Zhang, William C. Wright, Hongmei Cui, Zhidong Gu, Song‐Tao Liu, Kexi Wang and Aaron R. Tipton and has published in prestigious journals such as Cancer Research, Scientific Reports and The FASEB Journal.

In The Last Decade

Peter Oladimeji

17 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Oladimeji United States 13 287 148 95 89 81 17 519
Petra Koza‐Taylor United States 13 300 1.0× 111 0.8× 245 2.6× 58 0.7× 33 0.4× 22 692
Benny K. Abraham India 10 269 0.9× 438 3.0× 49 0.5× 113 1.3× 52 0.6× 13 724
Eva Berent Israel 13 481 1.7× 121 0.8× 32 0.3× 34 0.4× 77 1.0× 19 663
Zhenxin Yan United States 13 375 1.3× 113 0.8× 43 0.5× 19 0.2× 29 0.4× 20 521
Taekyu Park South Korea 11 278 1.0× 87 0.6× 36 0.4× 24 0.3× 27 0.3× 12 414
Xu Hannah Zhang United States 11 311 1.1× 60 0.4× 49 0.5× 24 0.3× 64 0.8× 19 619
Hideji Yako Japan 16 301 1.0× 90 0.6× 46 0.5× 15 0.2× 76 0.9× 39 625
David W. Dales Canada 9 201 0.7× 57 0.4× 61 0.6× 21 0.2× 36 0.4× 9 407
Maria Bürgin Switzerland 12 206 0.7× 42 0.3× 32 0.3× 44 0.5× 49 0.6× 18 470
G Brun France 11 231 0.8× 103 0.7× 51 0.5× 37 0.4× 29 0.4× 21 460

Countries citing papers authored by Peter Oladimeji

Since Specialization
Citations

This map shows the geographic impact of Peter Oladimeji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Oladimeji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Oladimeji more than expected).

Fields of papers citing papers by Peter Oladimeji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Oladimeji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Oladimeji. The network helps show where Peter Oladimeji may publish in the future.

Co-authorship network of co-authors of Peter Oladimeji

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Oladimeji. A scholar is included among the top collaborators of Peter Oladimeji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Oladimeji. Peter Oladimeji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Wright, William C., Jingheng Wang, Hazel M. Girvan, et al.. (2020). Clobetasol Propionate Is a Heme-Mediated Selective Inhibitor of Human Cytochrome P450 3A5. Journal of Medicinal Chemistry. 63(3). 1415–1433. 34 indexed citations
2.
Oladimeji, Peter, Jesse Bakke, William C. Wright, & Taosheng Chen. (2020). KANSL2 and MBNL3 are regulators of pancreatic ductal adenocarcinoma invasion. Scientific Reports. 10(1). 1485–1485. 7 indexed citations
3.
Bakke, Jesse, William C. Wright, Anthony E. Zamora, et al.. (2019). Genome-wide CRISPR screen reveals PSMA6 to be an essential gene in pancreatic cancer cells. BMC Cancer. 19(1). 253–253. 18 indexed citations
4.
Zhang, Shanshan, Zhaojian Gong, Peter Oladimeji, et al.. (2019). A high-throughput screening identifies histone deacetylase inhibitors as therapeutic agents against medulloblastoma. Experimental Hematology and Oncology. 8(1). 30–30. 19 indexed citations
5.
Oladimeji, Peter, William C. Wright, Jing Wu, & Taosheng Chen. (2018). RNA interference screen identifies NAA10 as a regulator of PXR transcription. Biochemical Pharmacology. 160. 92–109. 9 indexed citations
6.
Oladimeji, Peter & Taosheng Chen. (2017). PXR: More Than Just a Master Xenobiotic Receptor. Molecular Pharmacology. 93(2). 119–127. 133 indexed citations
7.
Oladimeji, Peter, et al.. (2017). Glucose-dependent regulation of pregnane X receptor is modulated by AMP-activated protein kinase. Scientific Reports. 7(1). 46751–46751. 18 indexed citations
8.
Oladimeji, Peter, et al.. (2016). Synergistic Activation of ERα by Estrogen and Prolactin in Breast Cancer Cells Requires Tyrosyl Phosphorylation of PAK1. Cancer Research. 76(9). 2600–2611. 22 indexed citations
9.
Oladimeji, Peter, Hongmei Cui, Chen Zhang, & Taosheng Chen. (2016). Regulation of PXR and CAR by protein-protein interaction and signaling crosstalk. Expert Opinion on Drug Metabolism & Toxicology. 12(9). 997–1010. 35 indexed citations
10.
Oladimeji, Peter & Maria Diakonova. (2016). PAK1 translocates into nucleus in response to prolactin but not to estrogen. Biochemical and Biophysical Research Communications. 473(1). 206–211. 7 indexed citations
11.
12.
Oladimeji, Peter, et al.. (2014). Phosphorylation of tyrosine 285 of PAK1 facilitates βPIX/GIT1 binding and adhesion turnover. The FASEB Journal. 29(3). 943–959. 15 indexed citations
13.
Rider, Leah, Peter Oladimeji, & Maria Diakonova. (2013). PAK1 Regulates Breast Cancer Cell Invasion through Secretion of Matrix Metalloproteinases in Response to Prolactin and Three-Dimensional Collagen IV. Molecular Endocrinology. 27(7). 1048–1064. 49 indexed citations
14.
Rider, Leah, et al.. (2013). Tyrosyl Phosphorylated PAK1 Regulates Breast Cancer Cell Motility in Response to Prolactin through Filamin A. Molecular Endocrinology. 27(3). 455–465. 32 indexed citations
15.
Tipton, Aaron R., et al.. (2012). Identification of novel mitosis regulators through data mining with human centromere/kinetochore proteins as group queries. BMC Cell Biology. 13(1). 15–15. 44 indexed citations
16.
Oladimeji, Peter, et al.. (2011). PAK1-Nck Regulates Cyclin D1 Promoter Activity in Response to Prolactin. Molecular Endocrinology. 25(9). 1565–1578. 36 indexed citations
17.
Hill, Matthew, Colin Campbell, Peter Oladimeji, et al.. (2010). Effects of cis-regulatory variation differ across regions of the adult human brain. Human Molecular Genetics. 19(22). 4490–4496. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Petra Koza‐Taylor Breakdown of academic impact, for papers by Benny K. Abraham Breakdown of academic impact, for papers by Eva Berent Breakdown of academic impact, for papers by Zhenxin Yan Breakdown of academic impact, for papers by Taekyu Park Breakdown of academic impact, for papers by Xu Hannah Zhang Breakdown of academic impact, for papers by Hideji Yako Breakdown of academic impact, for papers by David W. Dales Breakdown of academic impact, for papers by Maria Bürgin Breakdown of academic impact, for papers by G Brun
Rankless by CCL
2026